Subsequent Events (Details) - USD ($) |
1 Months Ended | 12 Months Ended | |||||||
|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2023 |
Apr. 05, 2023 |
Apr. 05, 2023 |
Jan. 15, 2023 |
Apr. 30, 2023 |
Dec. 31, 2021 |
Apr. 27, 2023 |
Feb. 22, 2023 |
Jan. 12, 2023 |
|
| Subsequent Events (Details) [Line Items] | |||||||||
| Amount spend | $ 213,974 | ||||||||
| Subsequent Event [Member] | |||||||||
| Subsequent Events (Details) [Line Items] | |||||||||
| Issued warrants (in Shares) | 400,000 | 400,000 | 2,571,429 | ||||||
| Exercise price per share (in Dollars per share) | $ 1,170,860 | $ 1,170,860 | $ 3.5 | ||||||
| Health insurance expenses | $ 407,135 | ||||||||
| Compensation committee | $ 10,000 | ||||||||
| Aggregate of shares (in Shares) | 1,570,680 | 1,570,680 | |||||||
| Purchase price per share (in Dollars per share) | $ 1.91 | $ 1.91 | |||||||
| Aggregate gross proceeds | $ 3,000,000 | ||||||||
| Exercise price per share (in Dollars per share) | $ 0.0001 | ||||||||
| Outstanding common stock percentage | 9.99% | ||||||||
| Warrants exercise price per share (in Dollars per share) | $ 1.78 | ||||||||
| Outstanding common stock percentage | 4.99% | ||||||||
| Pre-funded warrants | $ 1,170,860 | ||||||||
| Exercised warrants | $ 117 | ||||||||
| Amendment to common warrant agreements description | the Company entered into an Amendment to the common warrant agreements for the July 2022 and December 2022 Offerings, whereby the warrants to purchase up to 2,571,429 (with an original exercise price of $3.50 per share) and 306,604 shares (with an original exercise price of $1.06 per share), respectively, were amended to have an exercise price of $1.78 per share and for their expiration date to be extended to expire on October 10, 2028. | ||||||||
| Amendments reflect description | The Amendments reflect (a) an increase in the salary of each of Dr. Woody, Mr. Pamir and Dr. Rothbard of 3.5%, effective as of January 1, 2023; and (b) in the case of Mr. Pamir, a further increase in salary to $380,000 per annum and increase in his target bonus to 40%, effective April 1, 2023, as well as a change in his title from Interim Chief Financial Officer to Chief Financial Officer. | ||||||||
| Forecast [Member] | Minimum [Member] | |||||||||
| Subsequent Events (Details) [Line Items] | |||||||||
| Amount spend | $ 900,000 | ||||||||
| Forecast [Member] | Maximum [Member] | |||||||||
| Subsequent Events (Details) [Line Items] | |||||||||
| Amount spend | $ 1,000,000 | ||||||||
| Dr. Woody [Member] | Subsequent Event [Member] | |||||||||
| Subsequent Events (Details) [Line Items] | |||||||||
| Compensation committee | $ 111,675 | ||||||||
| Mr. Pamir [Member] | Subsequent Event [Member] | |||||||||
| Subsequent Events (Details) [Line Items] | |||||||||
| Compensation committee | 24,154 | ||||||||
| Dr. Rothbard [Member] | Subsequent Event [Member] | |||||||||
| Subsequent Events (Details) [Line Items] | |||||||||
| Compensation committee | $ 50,343 | ||||||||